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Sequence analysis of a 9-kb genomic fragment of the actinobacterium Rhodococcus opacus 1CP led to
identification of an open reading frame encoding a novel fusion protein, StyA2B, with a putative function in
styrene metabolism via styrene oxide and phenylacetic acid. Gene cluster analysis indicated that the highly
related fusion proteins of Nocardia farcinica IFM10152 and Arthrobacter aurescens TC1 are involved in a similar
physiological process. Whereas 413 amino acids of the N terminus of StyA2B are highly similar to those of the
oxygenases of two-component styrene monooxygenases (SMOs) from pseudomonads, the residual 160 amino
acids of the C terminus show significant homology to the flavin reductases of these systems. Cloning and
functional expression of His10-StyA2B revealed for the first time that the fusion protein does in fact catalyze
two separate reactions. Strictly NADH-dependent reduction of flavins and highly enantioselective oxygenation
of styrene to (S)-styrene oxide were shown. Inhibition studies and photometric analysis of recombinant StyA2B
indicated the absence of tightly bound heme and flavin cofactors in this self-sufficient monooxygenase. StyA2B
oxygenates a spectrum of aromatic compounds similar to those of two-component SMOs. However, the specific
activities of the flavin-reducing and styrene-oxidizing functions of StyA2B are one to two orders of magnitude
lower than those of StyA/StyB from Pseudomonas sp. strain VLB120.
The incorporation of one atom of oxygen during hydroxyla-
tion, epoxidation, sulfoxidation, or Baeyer-Villiger oxidation is
a common initial step of the aerobic degradation of aromatic
compounds by microorganisms. In bacteria, these reactions are
most frequently catalyzed by inducible flavoprotein monooxy-
genases (EC 1.14.13 [57]). The majority of these enzymes (so-
called single-component flavoprotein monooxygenases) utilize
electrons from NAD(P)H, which are transferred to a non-
covalently bound flavin adenine dinucleotide (FAD) in order
to activate molecular oxygen as a flavin (hydro)peroxide. De-
pending on the protonation of this intermediate and the type
of substrate, an oxygen atom is then incorporated by nucleo-
philic or electrophilic attack. More recently, different two-
component flavoprotein monooxygenases have been character-
ized (57). These systems cover an NAD(P)H-dependent flavin
reductase in order to generate reduced flavin and an oxygenase
that utilizes this cofactor for the activation of oxygen.
The exquisite regio- and stereoselectivities of oxygen inser-
tion by flavoprotein monooxygenases favor these enzymes for
biocatalytic applications (23, 24, 33). This is especially true
because chemical synthesis approaches by hetero- or homo-
genic catalysis often do not yield a sufficiently high enantio-
meric excess for the production of pharmaceuticals and their
chiral building blocks. The use of oxygen as an inexpensive
nontoxic oxidant and mild reaction conditions are additional
advantages with the potential for increasing the environmental
sustainability of oxygenase-catalyzed biotransformations.
The necessity for expensive cofactors is perhaps the most
striking drawback limiting the industrial application of flavo-
protein monooxygenases. Different electrochemical and enzy-
matic procedures for in vitro cofactor regeneration are avail-
able (20, 21, 32, 52, 56), but these systems are currently lacking
long-term stability. As a consequence, the practical application
of flavoprotein monooxygenases is virtually restricted to in vivo
systems in which cofactor regeneration is mediated by the
metabolism of the expression host (45, 49). The limitations of
whole-cell-mediated biotransformations by substrate and/or
product toxicity can be overcome by means of two-phase sys-
tems, as was recently shown for the two-component styrene
monooxygenase (SMO) from Pseudomonas sp. strain VLB120
(45).
Two-component flavoprotein monooxygenases present addi-
tional challenges for biocatalytic applications. The need for
two separate protein components may hamper attempts at
recombinant enzyme expression, the application of immobi-
lized enzymes in cell-free systems, and the detection of novel
oxygenases during activity-based metagenome-screening ap-
proaches. Moreover, and as was already shown for the two-
component SMO from Pseudomonas sp. strain VLB120 (44),
the interprotein transfer of reduced FAD is accompanied to a
certain extent by the auto-oxidative formation of reactive ox-
ygen species such as hydrogen peroxide (Fig. 1). Auto-oxida-
tion of reduced FAD not only decreases the efficiency of the
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oxygenation process but also negatively interferes with the
physiological conditions of the cell. The extent of oxidative
stress is considerably increased when FAD oxidoreductase ac-
tivity exceeds oxygenase activity and uncoupling becomes dom-
inant.
Presently the details of reduced-FAD transfer between the
oxygenase and FAD oxidoreductase components of SMOs are
not known. Recent kinetic studies have indicated that reduced
FAD is transferred by a mixed mechanism in which direct
contact of both proteins and free diffusion of the reduced
cofactor play a role (25). This hypothesis is supported by the
work of Otto and coworkers in which the formation of hydro-
gen peroxide was shown to be reciprocally proportional to the
concentration of active oxygenase StyA (44). The high level of
efficiency of self-sufficient cytochrome P450 enzymes com-
pared to that of multicomponent types is attributed to the
closer location between the heme-containing P450 domain (ox-
ygenase) and a reductase domain (FAD/flavin mononucleotide
[FMN] and NADH binding site), which should also promote
the efficiency of diffusive transfer (38). These self-sufficient
P450 systems are of high biocatalytic interest (8, 34, 39), and it
is likely that other types of self-sufficient monooxygenases (e.g.,
flavoenzymes) behave in a similar way.
Members of the gram-positive genus Rhodococcus are char-
acterized by their exceptionally high level of metabolic versa-
tility toward a broad range of organic substrates (31). Large
genome sizes, the presence of megaplasmids, and a distinct
gene redundancy (multiple enzyme homologs) favor these or-
ganisms as a promising source for novel enzymes (59). More-
over, several studies have provided evidence of functionally
convergent evolution of the catabolic activities of rhodococci
and proteobacteria (12, 37). Since most research on bacterial
catabolic activities has so far been performed on the latter
group, novel enzymes and mechanisms are likely to be identi-
fied in gram-positive bacteria.
The nocardioform actinobacterium Rhodococcus opacus
1CP was originally isolated from contaminated soil by enrich-
ment with 4-chloro- and 2,4-dichlorophenol as the sole carbon
sources (18). To solve questions related to the enzymes in-
volved in chlorophenol mineralization, an R. opacus 1CP clone
library was generated, leading to the identification of a 9-kb
genomic fragment harboring genes with a presumed function
in styrene metabolism. Sequence analysis indicated the pres-
ence of an open reading frame (ORF) encoding a fusion pro-
tein composed of an oxygenase and a reductase subunit with a
high level of similarity to the corresponding subunits of two-
component SMOs from pseudomonads. Recombinant expres-
sion and biochemical characterization confirmed that it has
enantioselective styrene epoxidation ability and showed that
StyA2B is the first representative of a new class of NADH- and
flavin-dependent single-component flavoprotein monooxygen-
ases.
MATERIALS AND METHODS
Chemicals and enzymes. Oxygenation substrates, (S)- and (R)-styrene oxide,
and cofactors were purchased from Sigma-Aldrich (Steinheim, Germany) and
Carl Roth (Karlsruhe, Germany). Enzymes used for cloning purposes were
obtained from MBI Fermentas (St. Leon-Rot, Germany) and Roche Diagnos-
tics. Oligonucleotides were synthesized by Eurofins MWG (Ebersberg, Ger-
many). 4-Chlorostyrene oxide, 4-methylstyrene oxide, and dihydronaphthalene
oxide were synthesized from the corresponding olefins (27).
Bacterial strains, plasmids, and culture conditions. The bacterial strains and
plasmids used in this study are listed in Table 1. R. opacus 1CP was kept on
mineral medium plates (9) with 54 mM sodium-potassium phosphate (pH 7.3)
containing 5 mM benzoate at 30°C. Fed batch cultivation on styrene was per-
formed in baffled 1-liter shaking flasks filled with 100 ml of the above mineral
medium (30°C; 120 rpm). In total, 60 to 120 l of styrene, corresponding to a
total substrate load of 5 to 10 mM, was added in 2.5- to 15-l portions over
several days by means of an evaporation adapter. Escherichia coli strains were
cultivated as described previously (50).
GC-MS-based metabolite detection during growth of R. opacus 1CP on sty-
rene. The clear supernatant (20 min; 16,000  g; 4°C) from 5 ml of an actively
growing styrene culture (optical density at 600 nm [OD600], 0.3 to 1.5) was
subjected to immersion solid phase microextraction (polydimethylsiloxane/divi-
nylbenzene phase) (Supelco). After desorption, analytes were separated by two-
dimensional gas chromatography (GC) (7890A GC system; Agilent) with RTX-5
(10 m; Restek) and RTX-17 (1.2 m; Restek) columns, using the following tem-
peratures: 40°C (1 min), 40 to 60°C (plus 10°C min1), 60 to 100°C (plus 4°C
min1), 100°C (1 min), and 100 to 250°C (plus 15°C min1). Spectra were
detected using time-of-flight mass spectrometry (MS) (Pegasus 4D GCxGC-
TOFMS; Leco) with an ionization field of 70 eV and a detector voltage of
1,450.
DNA techniques and purification of nucleic acids. Genomic DNA from R.
opacus 1CP was prepared as described previously (37), and standard protocols
were used for DNA cloning, transformation, and nucleic acid purification
(22, 50).
Construction and functional screening of a clone library. Genomic 1CP DNA
was partially digested with Sau3AI to get 3- to 6-kb fragments. Ligation in
BamHI-digested dephosphorylated pBluescript II KS() and transformation
into E. coli DH5 yielded a clone library. Transformants were plated onto LB
agar (100 g ml1 ampicillin) and incubated at 37°C for 24 h. Following a 1-week
incubation at 4°C, grown colonies were screened for blue coloration.
Restriction analysis, subcloning, and DNA sequencing of p1CPS1 and
p1CPS2. Subclones of pBluescript II KS() p1CPS1 and pBluescript II KS()
p1CPS2 were generated using restriction endonucleases ApaI, BamHI, EcoRI
(only for p1CPS1), PstI, SacI, SacII, SmaI (only for p1CPS2), and XhoI. DNA
sequencing was performed according to a dye terminator sequencing cycle pro-
tocol (54) and using Lasergene 99 program package v4.05 (Dnastar) and BLAST
(2, 3) for sequence analysis.
Localization of overlapping clone p1CPS2 by hybridization. Digoxigenin
(DIG) labeling, blotting, hybridization, and detection procedures were per-
formed as described previously (29). A 688-bp BamHI/SpeI fragment of plasmid
p1CPS1 served as a template for probe preparation, and genomic 1CP DNA was
digested with the endonucleases ApaI, BamHI, EcoRI, and PstI.
Construction of expression clones for StyA1 and StyA2B. Genes styA2B and
styA1 were amplified from genomic 1CP DNA by PCR (annealing temperature,
61°C), using the appropriate primers (Table 1). Purified products of correct size
(styA2B, 1,722 bp; styA1, 1,221 bp) were cloned into a T vector of pBluescript II
KS() (35) and pJET1.2/blunt to yield pSRoA2B_B01 and pSRoA1_B01, re-
spectively. Following double digestion by NdeI/NotI, styA2B and styA1 were
transferred in pET16bP to yield expression constructs pSRoA2B_P01 and
FIG. 1. Catalytic mechanism of two-component SMOs and the for-
mation of oxidative stress by uncoupling between FAD oxidoreductase
(StyB) and oxygenase (StyA) (adapted from reference 36). FADOX
and FADRED, oxidized and reduced forms of FAD, respectively.
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pSRoA1_P01, from which recombinant proteins were obtained as His10-tagged
fusion proteins.
Expression, purification, and proteolytic cleavage of His10-StyA2B. Recombi-
nant expression took place in a 5-liter biofermenter (ADI 1030 biocontroller;
Applikon). For that purpose, E. coli BL21(pSRoA2B_P01) was cultivated in 4
liters of LB medium (100 g ml1 ampicillin and 35 g ml1 chloramphenicol)
at 30°C (600 rpm; 0.3 standard liters of air per minute) to an OD600 of 0.7. The
addition of 0.1 mM IPTG (isopropyl--D-thiogalactopyranoside) was followed by
an induction period of 27 h at 20°C. Cells were harvested by centrifugation,
resuspended in 27 mM sodium-potassium phosphate (pH 7.3), and stored at
80°C.
Crude extract was prepared from the freshly thawed biomass after it was
diluted with a threefold excess of 10 mM Tris HCl (pH 7.5) containing 2 mM
dithiothreitol (DTT) as described previously (54).
Purification of His10-StyA2B was achieved by Ni chelate chromatography on a
1-ml HisTrap FF column, using an A¨KTA fast-performance liquid chromatog-
rapher (both from GE Healthcare). After the application of a crude extract of E.
coli BL21(pSRoA2B_P01) (290 mg total protein), nonspecific proteins were
removed with binding buffer (10 mM Tris HCl [pH 7.5], 2 mM DTT, 0.5 M NaCl,
25 mM imidazole). His10-StyA2B was eluted with a linear imidazole gradient of
25 to 500 mM in that buffer over 10 column volumes. Fractions with NADH-
dependent FAD oxidoreductase activity were pooled and subjected to ammo-
nium sulfate precipitation (80% saturation). Recombinant protein was collected
by centrifugation, washed two times with 10 mM Tris HCl (pH 7.3) containing 4
M ammonium sulfate and 0.5 mM disodium EDTA, dissolved in storage buffer
(100 mM Tris HCl [pH 7.25] containing 50% [vol/vol] glycerol, 5 mM DTT, and
100 mM ammonium sulfate) to a final concentration of 16 mg ml1, and stored
at 20°C.
Attempts to express His10-StyA1 by means of E. coli BL21(pSRoA1_P01) were
restricted to 50-ml cultures in shaking flasks, since all conditions tested (0.1 to 1.0
mM IPTG; 20 to 30°C induction temperature) led exclusively to inactive inclu-
sion bodies.
Estimation of molecular size of His10-StyA2B. Discontinuous sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (50) and size exclusion
chromatography on a Superdex 200 HR 16/60 column (GE Healthcare) were
applied in order to determine the molecular sizes of denatured and native
enzymes, respectively. For the latter technique, 100 mM Tris HCl (pH 7.5)
containing 150 mM NaCl served as the mobile phase and low- and high-molec-
ular-weight reference proteins (Amersham Pharmacia) were used for size cali-
bration.
Protein determination and flavin and metal content analysis. Protein concen-
trations were determined with the Bradford method (6), using protein assay
reagent (Bio-Rad). Bovine serum albumin (Sigma) served as the reference pro-
tein. His10-StyA2B concentrations in small sample volumes were alternatively
determined at 280 nm, using a NanoDrop photometer (Peqlab).
The flavin content of homogeneous His10-StyA2B was determined spectro-
photometrically by applying a molecular absorption coefficient of ε450 nm 11.3
mM1 cm1 for free FAD (46). The metal content of a solution of 0.65 mg ml1
His10-StyA2B in 1% ultrapure HNO3 was analyzed by inductively coupled plasma-
atom emission spectroscopy using an iCAP 6500 instrument (Thermo Fisher
Scientific) and compared to data obtained from a blank probe without protein.
SMO activity assays and inhibition studies. StyA2B activity was determined
with respect to reduced flavin components at the expense of NAD(P)H as well
as its ability to convert styrene or related substrates to the corresponding oxides.
Flavin oxidoreductase activity was measured spectrophotometrically following
NADH consumption at 340 nm (Cary 50; Varian). The standard assay contained
the following in a final volume of 1 ml: 20 mol Tris HCl (pH 7.5), 0.175 mol
NADH, 0.050 mol FAD, and an appropriate amount of recombinant StyA2B.
After 10 min of preincubation at 30°C, the reaction was started by adding
NADH. In order to determine enzyme specificity, NADPH, FMN, and riboflavin
were applied as alternative cosubstrates. Initial reaction rates were measured
using 4 to 60 M flavin-containing electron acceptor and 17.5 to 175 M NADH.
Kinetic parameters (Km and Vmax) were obtained by the nonlinear least-squares
TABLE 1. Strains, plasmids, and primers used in this study
Strain, plasmid, or primer Relevant characteristic(s)a Source orreference(s)
Strains
R. opacus 1CP Benzoate, 4-hydroxybenzoate, 3-chlorobenzoate, phenol, 4-chlorophenol, 2,4-
dichlorophenol, 2-chlorophenol, 3-methylphenol, 4-methylphenol,
phthalate, isophthalate, n-alkanes (C10-C16), and styrene
b
18, 37
E. coli DH5 F 	80dlacZM15 (lacZYA-argF)U169 endA1 recA1 hsdR17(rK
 mK
) supE44 

thi-1 gyrA96 relA1
Gibco-BRL
E. coli BL21(DE3)
(pLysS)
hsdS gal (
cIts857 ind1 Sam7 nin5 lacUV5-T7 gene 1) pLysS (Cmr) Stratagene
Plasmids
pBluescript II KS() Phagemid derived from pUC19; Plac lacZ Ap
r; f1() origin; ColE1 origin Stratagene
pJET1.2/blunt Contains a gene coding for a lethal restriction enzyme; a gene disrupted by ligation
of a DNA insert into the cloning site is possible; T7 promoter
Fermentas
pET16bP pET16b with additional multicloning site; allows expression of recombinant proteins
with N-terminal His10 tag
U. Wehmeyerc
p1CPS1 5,542-kb Sau3AI fragment of genomic R. opacus 1CP DNA in pBluescript II KS() This study
p1CPS2 4,850-kb EcoRI fragment of genomic R. opacus 1CP DNA in pBluescript II KS() This study
pSRoA2B_B01 styA2B of R. opacus 1CP (PCR product with primers 1CP_A2B_fw/1CP_A2B_rev)
cloned into the EcoRV site of pBluescript II KS()
This study
pSRoA2B_P01 styA2B of R. opacus 1CP (1.722-kb NdeI/NotI fragment) cloned into pET16bP This study
pSRoA1_B01 styA1 of R. opacus 1CP (PCR product with primers 1CP_A1_fw/1CP_A1_rev)
cloned into pJET1.2/blunt
This study
pSRoA1_P01 styA1 of R. opacus 1CP (1.221-kb NdeI/NotI fragment) cloned into pET16bP This study
Primers
1CP_A1_fw 5-CATATGCGCAAGATCACCATCGTT-3; includes NdeI site This study
1CP_A1_rev 5-GCGGCCGCGAGTGCTAGTTC-3; includes NotI site This study
1CP_A2B_fw 5-CATATGCGCAGCATCGCTAT-3; includes NdeI site This study
1CP_A2B_rev 5-GCGGCCGCTCAGAAGTCG-3; includes NotI site This study
T3 5-CGCGCAATTAACCCTCACTAAAG-3; IRD800 labeled Eurofins MWG
T7 5-GCGCGTAATACGACTCACTATAG-3; IRD800 labeled Eurofins MWG
a Underlined primer regions indicate corresponding gene sequences.
b Plus signs indicate growth substrates.
c Personal communication.
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regression method by means of DynaFit 3.24 software (30), assuming Michaelis-
Menten kinetics.
The optimum temperature and pH for oxidoreductase activity were deter-
mined by a standard assay at temperatures between 10 and 50°C; the buffer was
replaced at 30°C with similar amounts of succinate HCl (pH 5.0 to 6.0), Bis-
Tris-propane HCl (pH 6.25 to 9.0), and bis-Tris HCl (pH 5.75 to 7.25).
The sensitivity of the FAD oxidoreductase activity of StyA2B toward inhibitors
(after 10 min of incubation) was tested by the standard assay with the following
added (M): styrene (2,000), thioanisole (2,000), styrene oxide (100 and 200),
methylphenylsulfide (100 and 200), hydrogen peroxide (100), Mg2 (20), Ca2
(20), Fe2 (100), Cd2 (10), Hg2 (10), Na2EDTA (10,000), DTT (500),
o-phenanthroline (10), metyrapone (100), mercaptoethanol (500), thiourea (10),
or sodium azide (500). Metals were applied as chlorides or sulfates. In the case
of Hg2, 0.4 mg of bovine serum albumin was added prior to the addition of
NADH to avoid artificial complex formation. Reactivation after Cd2 treatment
was tested by incubation with 100 M DTT for 10 min.
The oxygenase activity of recombinant StyA2B with styrene was measured by
quantification of the reaction product. A typical oxygenase assay was performed
in a 3-ml glass vial fitted with a Teflon-coated septum and placed in a continu-
ously shaken (750 rpm) thermoblock. The standard reaction mixture contained
the following in a final volume of 250 l: 5 mol Tris HCl (pH 7.5), 0.25 mol
DTT, 5% (vol/vol) glycerol, 37.5 mol formate, 0.5 U formate dehydrogenase
(from Candida boidinii; Fluka), 650 U catalase (from bovine liver; Fluka), 43.8
nmol NADH, 12.5 nmol FAD, 0.5 mol styrene (100 mM in ethyl alcohol), and
an appropriate amount of StyA2B (adapted from reference 44). After a 10-min
preincubation at 30°C, the reaction was started by the addition of the substrate
by means of a GC syringe (Hamilton). Samples (25 l) were taken at different
intervals, the reaction was quenched by the addition of the same volume of
acetonitrile, and the samples were centrifuged (10,000  g; 10 min) and sub-
jected to reverse phase high-performance liquid chromatography (HPLC).
For the determination of oxygenase specificity, substitutions of similar con-
centrations of 4-chlorostyrene, 4-methylstyrene, dihydronaphthalene, and thio-
anisole were made for styrene. Reaction rates (measured in triplicate) were
determined from the initial slope of product formation, and relative velocities
were calculated by comparing the obtained specific activities to that for styrene
(100%).
Formation of chiral epoxides by means of whole-cell biotransformation. In-
duced cells of E. coli BL21(pSRoA2B_P01) were harvested by centrifugation and
resuspended in 20 ml 27 mM sodium-potassium phosphate (pH 7.3) to give a
final OD600 of 20. After being transferred in a 250-ml baffled shaking flask, 2 mM
glucose and 1 mM styrene or 4-chlorostyrene (100 mM in dimethylformamide)
were added, and incubation took place at 37°C in a shaker (120 rpm) for 24 h.
After the removal of cells by centrifugation, clear supernatants were subjected to
solvent (3 1 ml hexane) extraction. The combined organic phase sample was
dried with anhydrous sodium sulfate and freed from the solvent under reduced
pressure. When a final volume of approximately 50 l was reached, the sample
was subjected to chiral HPLC.
HPLC. Reverse phase HPLC analyses of products from StyA2B-mediated
oxygenations were performed on a vertex column packed with Eurospher
C18 (125-mm length by 4-mm internal diameter; 5-m particle size; 100-Å pore
size; Knauer, Germany). Acetonitrile-water was used as the mobile phase (1.0 ml
min1). Styrene oxide (net retention volume, 1.78 ml; 60% [vol/vol] acetonitrile),
4-chlorostyrene oxide (2.74 ml; 60%), 4-methylstyrene oxide (2.45 ml; 60%), and
methylphenylsulfoxide (0.89 ml; 50%) were separated in the isocratic mode, and
dihydronaphthalene oxide (5.20 ml) was eluted during a linear gradient of 40 to
75% (vol/vol) acetonitrile over 11 ml. The retention volumes and UV spectra
(200 to 400 nm) of all products were compared to those of authentic standards.
Absorbance at 210 nm was used for quantification and was applied to multipoint
calibrations.
For chiral HPLC and in order to separate (R)- and (S)-styrene oxides, a
Nucleodex -PM column (250-mm length by 4-mm internal diameter; Macherey-
Nagel, Germany) was used for the stationary phase in the isocratic mode (40%
[vol/vol] methanol; 0.1% [vol/vol] triethyl ammonium acetate [pH 4.0]; 0.7 ml
min1). Due to the lack of authentic standards, assignment of the (S)- and
(R)-enantiomers of 4-chlorostyrene oxide (65.68 ml and 74.49 ml, respectively)
was based on comparison to the retention behavior of the corresponding enan-
tiomers of styrene oxide (51).
Nucleotide sequence accession number. The 8,965-bp genomic consensus se-
quence of p1CPS1 and p1CPS2 has been deposited at GenBank under accession
no. FJ403049; also, see Fig. S1 in the supplemental material.
RESULTS AND DISCUSSION
Identification of two indole-oxidizing clones harboring pu-
tative monooxygenases of R. opacus 1CP. In an attempt to
identify genes of chlorophenol hydroxylases by means of a
clone library, partially Sau3AI-digested genomic DNA of R.
opacus 1CP was cloned into the unique BamHI restriction site
of pBluescript II KS(). The obtained transformants were
screened for their indigo formation ability on LB medium. The
ability to oxidize indole (available from tryptophan by the
action of an E. coli tryptophanase) to indigo is a property that
is applicable for the detection of certain monooxygenase ac-
tivities (26, 42). One single clone (p1CPS1) was found to react
positively, growing as a dark-blue-centered colony. Preliminary
sequence analysis of the 5,542-bp insert of that clone indicated
the presence of two ORFs with high levels of similarity to a
large number of monooxygenases. One of these monooxygen-
ase-like genes was incomplete; thus, an overlapping clone,
p1CPS2 (4,850-bp insert), was obtained by hybridization, using
a DIG-labeled region of that ORF as a probe. Colonies of
clone p1CPS2 showed phenotypic behavior similar to that of
p1CPS1 in respect to the ability to generate indigo from indole.
R. opacus 1CP mineralizes styrene via styrene oxide and
probably by an aerobic phenylacetic acid (PAA) pathway. In
order to confirm the first functional indications of the two
monooxygenases encoded on the genomic fragment, strain
1CP was checked for its ability to mineralize styrene. Like
benzene, toluene, and the xylenes, the hydrocarbon styrene
behaves as a typical solvent, and due to an octanol-water par-
tition coefficient below 4 (log P 2.95), it is extremely toxic for
microorganisms (47). Accumulation within the cytoplasmic
membrane followed by its disruption is the most likely mode of
action. Lack of success at attempts to cultivate strain 1CP in
liquid mineral medium in the presence of a styrene-saturated
vapor phase can be attributed to this distinct sensitivity. How-
ever, after decreasing the size of the styrene aliquots that were
frequently added through the evaporation adapter, this hydro-
carbon was found to serve as the sole carbon and energy source
for strain 1CP. Not surprisingly, the sizes of the added styrene
aliquots could later be adapted for the growing culture. An
OD600 of up to 1.5 was obtained for a supplied total styrene
concentration of 10 mM.
An exponentially growing styrene culture was analyzed for
intermediates by means of GC-MS in order to get information
on the type of degradation pathway. Two metabolites, both
with mass peaks of 120 m/z and a strong signal of 91 m/z for the
tropylium ion (C7H7)
 were detected in the aqueous culture
supernatant. Both MS spectra and the retention behavior of
these intermediates were shown to be identical to authentic
references for styrene oxide and phenylacetaldehyde (data not
shown; MS spectra are shown in Fig. S2 in the supplemental
material). This observation strongly indicates that styrene is
initially degraded by a monooxygenase-catalyzed epoxidation
of the vinyl side chain. The resulting styrene oxide may then be
further converted to phenylacetaldehyde by the action of an
epoxystyrene isomerase (Fig. 2). Such a pathway of side chain
oxygenation is the most common for the aerobic degradation
of styrene and has been described for several strains of the
proteobacterial genera Pseudomonas and Xanthobacter (re-
viewed by O’Leary and coworkers [43]). Taking into account
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this catabolic route, phenylacetaldehyde may be further oxi-
dized to PAA by the action of a phenylacetaldehyde dehydro-
genase. Attempts to detect PAA from the above culture su-
pernatant of strain 1CP failed. However, PAA serves as a good
growth substrate for R. opacus 1CP (5 mM PAA yielded an
OD600 of 1.27), indicating the presence of a complete catabolic
pathway for this compound.
Analysis of a 9-kb genomic fragment of strain 1CP harbor-
ing a hypothetical self-sufficient SMO. The overlapping inserts
of p1CPS1 and p1CPS2 allowed the characterization of an
entire 8,965-bp genomic region of strain 1CP harboring nine
ORFs (Fig. 3a). Incomplete ORF1 encodes the N-terminal
part of a protein with similarity to putative regulators of PAA
metabolism (1, 17) (Table 2). Considering that styrene is usu-
ally degraded via side chain oxygenation to this intermediate
(Fig. 2) (5), similarity to proteins involved in PAA degradation
is not unexpected. Also relevant in this respect is ORF2, which
encodes a putative 538-amino-acid (aa) AMP-dependent acyl
coenzyme A (acyl-CoA) ligase. PAA-CoA ligases, which be-
long to this class of enzymes, are responsible for the degrada-
tion of PAA. ORF3, which may be transcribed with ORF2,
encodes a 264-aa protein with a high level of similarity to a
large number of putative short-chain dehydrogenases.
The two coding regions of the highest interest, ORF4 and
ORF5, were obviously responsible for the indole-oxidizing ac-
tivity of p1CPS1 and p1CPS2. ORF4 was designated styA1,
since the deduced protein showed a high level of similarity to
a large number of oxygenase subunits of putative two-compo-
nent SMOs. The very few among them whose activity was
experimentally proven are SMOs from pseudomonads (e.g.,
the main component, StyA, of Pseudomonas fluorescens strain
ST [4]) or from an uncultured bacterium (subunit A [61])
(Table 2).
ORF5, which is cotranscribed and located directly down-
stream of ORF4, was found to be most remarkable, since the
encoded protein seems to represent a fusion between an oxy-
genase and a flavin oxidoreductase. The N-terminal segment
(105 to 108 identical amino acids over a length of 399 aa) of the
deduced protein showed 26 to 27% sequence identity to oxy-
genase components of two-component SMOs from pseudo-
monads, whereas the C-terminal segment (51 to 54 identical
amino acids over a length of 151 to 155 aa) was similar to the
corresponding flavin reductase components of such systems
(32 to 34% sequence identity). Accordingly, ORF5 was desig-
nated styA2B.
Incomplete ORFs 6 and 9 encode a 143-aa N-terminal and
a 26-aa internal segment, respectively, of a hypothetical
dienelactone hydrolase. Enzymes such as dienelactone hydro-
lase are usually involved in the modified ortho-cleavage path-
way of chlorocatechols (41).
The encoded proteins of ORF7 and ORF8 are highly related
to transposases (Table 2), and inverted repeats that possibly
terminate the two slightly overlapping insertion elements were
identified (for ORF7, 6575-TACTAGGGCGTGTCTCCCAA
TGATTTG-6601 and 7539-ATCATCCCGTACAGAGGGTT
ATCAAAC-7513; for ORF8, 7531-GCCCTACTACTGCAAC
GGCACTT-7553 and 8893-CGGCATCATGACGTTGCCGT
GAA-8871). The transposons were obviously integrated one
after another into the dienelactone hydrolase gene.
FIG. 2. Proposed styrene metabolic pathway via vinyl side chain
oxygenation in R. opacus 1CP. The involved enzymes comprise SMO,
styrene oxide isomerase (SOI), phenylacetaldehyde dehydrogenase
(PAD), and multiple enzymes of phenylacetate degradation (PAA#)
leading to intermediates of the tricarboxylic acid cycle (TCA).
FIG. 3. Location of styA1 and styA2B on the 8.965-kb region of genomic R. opacus 1CP DNA (a) and comparison to chromosomal regions of
A. aurescens TC1 (CP000474) and N. farcinica IFM10152 (AP006618) (b), both harboring genes for similar putative self-sufficient monooxygenases.
Inserts of p1CPS1, p1CPS2, and expression plasmids for styA1 and styA2B are shown. Gray shading indicates a terminal 688-bp fragment of p1CPS1
used as a DIG-labeled probe for identification of p1CPS2. Locus tags are given for the first and last genes of the genomic regions compared.
Identical hatching indicates a similar protein function. SDR, short-chain dehydrogenase; DLH, dienelactone hydrolase; put., putative.
5000 TISCHLER ET AL. J. BACTERIOL.
 at W
ageningen UR Library on August 23, 2009 
jb.asm.org
D
ow
nloaded from
 
Localization of styA2B-like genes in other genomes. A
BLAST search of StyA2B with the available sequence data
allowed the identification of two other styA2B-like “merged”
genes in the chromosomes of Nocardia farcinica IFM10152 and
Arthrobacter aurescens TC1. The encoded proteins were desig-
nated as a putative oxygenase (BAD56094) and putative
monooxygenase component B (ABM10099), respectively, and
both were recently suggested to represent SMOs (60).
Comparison of adjacent ORFs to those found on the 9-kb
genome fragment of strain 1CP yielded a number of structural
homologies, giving at least a hint that StyA2B (R. opacus 1CP),
BAD56094 (N. farcinica IFM10152), and ABM10099 (A. au-
rescens TC1) (Fig. 3b) may fulfill a similar physiological func-
tion, which is probably part of styrene metabolism. Most re-
markably, the genes of the hypothetical fusion SMOs of strains
IFM10152 and TC1 are both located directly adjacent to an
ORF encoding a protein highly similar to the N-terminal oxy-
genase-like segment of BAD56094 and ABM10099, respec-
TABLE 2. Identified ORFs on the 8,965-bp consensus sequence of p1CPS1 and p1CPS2 inserts and similarities of deduced proteins
ORF
(gene)
Product size
(aa)a Position of start-stop codon
a Gene product description (bacterium)b
NCBI
accession
designation
No. of identical
amino acids/no.
of amino acids
in aligned
region (%
identity)
1 112i 337–1i Hypothetical protein (N. farcinica
IFM10152)
BAD56096 54/78 (69%)
Repressor of PAA catabolism
(Saccharopolyspora erythraea NRRL2338)
CAM02415 62/104 (59%)
Putative transcriptional regulator; PaaX-like
protein family (A. aurescens TC1)
ABM07064 34/79 (43%)
2 539 435–2051 AMP-dependent acyl-CoA synthetase
(S. erythraea NRRL2338)
CAM02409 363/533 (68%)
Putative acyl-CoA synthetase (N. farcinica
IFM10152)
BAD56088 355/536 (66%)
Putative acyl-CoA synthetase/AMP-fatty
acid ligase (A. aurescens TC1)
ABM09333 326/535 (60%)
3 265 2312–3106 Short-chain dehydrogenase (Burkholderia
vietnamiensis G4)
ABO59359 162/259 (62%)
Short-chain dehydrogenase (N. farcinica
IFM10152)
BAD56092 163/263 (61%)
Short-chain dehydrogenase (A. aurescens
TC1)
ABM07464 156/258 (60%)
4 (styA1) 407 3131–4351 Putative oxygenase (N. farcinica IFM10152) BAD56093 296/406 (72%)
Putative oxidoreductase (A. aurescens TC1) ABM07034 275/408 (67%)
Main component of SMO; StyA
(P. fluorescens ST)
CAB06823 125/414 (30%)
SMO large component (Pseudomonas sp.
strain VLB120)
AAC23718 123/414 (29%)
5 (styA2B) 574 4387–6108 Putative oxygenase (N. farcinica IFM10152) BAD56094 341/578 (58%)
Putative monooxygenase component B
(A. aurescens TC1)
ABM10099 311/583 (53%)
SMO large component (Pseudomonas sp.
strain VLB120)
AAC23718 107/399 (26%)
SMO small component (Pseudomonas sp.
strain VLB120)
AAC23719 51/155 (32%)
6 and 9c 143i and 26 6152–6580i and 8888–8965i Putative dienelactone hydrolase
(Burkholderia cenocepacia J2315)
CAR55985 98/166 (59%)
Carboxymethylenebutenolidase
(Burkholderia xenovorans LB400)
ABE35672 97/165 (58%)
Carboxymethylenebutenolidase
(Burkholderia sp. strain H160)
EDZ99576 97/167 (58%)
7 290 6707–7576 Putative transposase (Rhodococcus sp.
strain RHA1)
ABG99655 263/275 (95%)
Transposase (R. opacus R7) ABH01025 171/199 (85%)
Transposase; IS4 family protein
(Mycobacterium vanbaalenii PYR-1)
ABM11341 113/184 (61%)
8 378 7581–8714 Putative transposase (Rhodococcus sp.
strain RHA1)
ABH00342 364/377 (96%)
Transposase; IS4 family protein (Frankia sp.
strain EAN1pec)
ABW12678 259/370 (70%)
Putative transposase (Streptomyces sp. strain
HK1)
ABY83494 204/359 (56%)
a A superscript “i” indicates an incomplete sequence.
b As given in the NCBI database.
c Continuation of ORF6; ORFs 6 and 9 were fused and analyzed for similarities as one amino acid sequence.
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tively, a finding that is consistent with the styA1-styA2B system
of R. opacus 1CP, and as in strain 1CP, the ORFs of strains
IFM10152 and TC1 are both potential subjects of cotranscrip-
tion. Another striking similarity in all three organisms is the
presence of an adjacent ORF encoding a short-chain dehydro-
genase-like protein of hitherto unknown function. The pres-
ence of additional ORFs encoding a putative PaaX-like regu-
lator and a putative acyl-CoA synthetase is another striking
similarity between strains 1CP and IFM10152, which led to the
assumption that StyA1/StyA2B may in fact be responsible for
the initial degradation of styrene, which in the most common
degradation pathway yields PAA as an intermediate (Fig. 2). It
should be mentioned that although a PaaX-like regulator and
an acyl-CoA synthetase of A. aurescens TC1 are located else-
where on the chromosome (Aaur_4024 and Aaur_4030), the
two genes are located close to each other.
Structural properties of StyA1 and StyA2B and their related-
ness to other SMOs. From the above results, it seems likely that
styA1 and styA2B encode components of SMOs. A multiple-
sequence alignment of StyA1 and StyA2B with SMOs of
known function revealed the presence of conserved sequence
motifs typical for a mechanistic involvement of flavins and
nicotinamide adenine dinucleotides (Fig. 4). The FAD-binding
fingerprints GxGxxG, GG, and Dx6G (15) were found in both
StyA1 and StyA2B proteins at amino acid positions 8, 118
(StyA1, 117), and 139 (StyA1, 138), respectively. In addition,
Ser46 and Pro299 of StyA2B as well as Pro298 of StyA1 likely
correspond to highly conserved amino acids necessary for the
activity of SMOs (15). Pro299 (StyA2B) and Pro298 (StyA1)
both belong to a Gdx6P sequence motif important for FAD/
NAD(P) interaction. Finally, the residual C-terminal part of
StyA2B (approximate position, aa 414 to 573; 160 aa) is highly
conserved and similar to those of flavin reductases, which use
NAD(P)H as a cofactor in order to reduce flavin-containing
cosubstrates. Note that no flavin-binding motif could be found
in the reductase domain.
Comparison of the fusion with the C-terminal StyA and
N-terminal StyB regions indicates that fused SMOs lack 10
(Pseudomonas spp.) to 14 (Delftia acidovorans) amino acids of
the N-terminal part of StyB.
The phylogenetic relatedness of StyA2B was determined
with respect to its oxygenase and oxidoreductase moiety (Fig.
5). Since so far only a very few two-component SMOs have
been assigned by experimental evidence, most sequences taken
from genomes represent monooxygenases of unknown speci-
ficity. The dendrogram in Fig. 5 indicates the highest level of
relatedness among all three hypothetical one-component
SMOs from R. opacus 1CP (StyA2B), N. farcinica IFM10152
(BAD56094), and A. aurescens TC1 (ABM10099) for both
oxygenase and flavin oxidoreductase moieties. Together with
StyA1 from R. opacus 1CP, the single oxygenase components
of these organisms form a separate cluster that is distinct from,
but still closely related to, the cluster of the N-terminal oxy-
genase moieties of one-component SMOs. This finding sug-
gests that the presumed fusion of oxygenase and flavin oxi-
doreductase moieties occurred only in the SMO branch of
these Actinobacteria and is not an ancient feature among
SMOs (Fig. 5).
Overexpression, purification. and size determination of re-
combinant His10-StyA1 and His10-StyA2B in E. coli. In order
to characterize StyA1 and StyA2B in more detail, both genes
were amplified with specific primers and cloned into a pET16b
(Novagen) vector derivative to give pSRoA1_P01 and
pSRoA2B_P01, respectively. Expression of the His10-tagged
proteins was performed in E. coli BL21, and the efficiency of
expression was tested at 20°C, 30°C, and 37°C in the presence
of 0.1 mM and 1.0 mM of IPTG. During the induction period,
a green-to-blue coloration of the cultures, faint for
pSRoA1_P01 and distinct for pSRoA2B_P01, was the first
evidence of the expression of active monooxygenases. In fact,
SDS-PAGE of the cytosolic and insoluble fraction indicated
successful expression of soluble His10-StyA2B, of which the
highest yields were obtained by induction at 20°C in the pres-
ence of 0.1 mM IPTG. The recombinant protein appeared as a
dominant band at around 65 kDa, which fits well with the
calculated size of 64,329 Da (Fig. 6a).
His10-StyA2B was purified to homogeneity by Ni chelate
chromatography. As a result, 32 mg of His10-StyA2B, account-
ing for 11% of the total protein, was obtained from E. coli
BL21(pSRoA2B_P01). Storage of the protein at 20°C in the
presence of glycerol-DTT proved to be the most gentle method
to minimize inactivation.
Size exclusion chromatography of the final His10-StyA2B
preparation yielded a single symmetrical protein peak corre-
sponding to a molecular mass of 138  2 kDa for the native
enzyme, which indicates a homodimeric structure. Interest-
ingly, a similar organization was reported for both the oxygen-
ase component StyA and the oxidoreductase component StyB
of the two-component SMO from Pseudomonas sp. strain
VLB120 (44).
In the case of His10-StyA1, SDS-PAGE produced a domi-
nant band at 44.8  0.5 kDa (calculated size, 46,537 Da),
indicating recombinant expression. Unfortunately, the protein
could be found only in the insoluble cell fraction, indicating the
exclusive formation of inclusion bodies. Neither reducing the
growth temperature down to 20°C nor decreasing the IPTG
concentration to 0.1 mM brought about a detectable yield of
active enzyme in the cytosol (data not shown).
StyA2B shows NADH-specific FAD oxidoreductase activity.
Due to its protein sequence similarities, recombinant StyA2B
was characterized as both a flavin reductase and an oxygenase.
The oxidoreductase-like moiety of StyA2B was analyzed for its
specificity toward several flavin-containing electron acceptors
and the electron donor NAD(P)H (Table 3). As in the two-
component SMO from Pseudomonas sp. strain VLB120 (44),
activity was specifically restricted to NADH, whereas FAD,
FMN, and riboflavin were shown to serve as flavin substrates.
The utilization of different flavins as electron acceptors is typ-
ical for NADH-dependent flavin oxidoreductases that do not
contain a tightly bound flavin (44), and spectrophotometrical
analysis confirmed that StyA2B shares this characteristic (see
below). On the other hand, flavin reductases that harbor a
flavin prosthetic group use a second free flavin for electron
transfer (28). FAD, FMN, and riboflavin were reduced by
His10-StyA2B with comparable turnover numbers (3.0 to 5.2
s1), whereas the Michaelis constants for these compounds
decreased in the following order: that for FMN (67 M) was
greater than that for FAD (26 M), which was greater than
that for riboflavin (23 M). Affinity constants in the micromo-
lar range indicate that these flavins act as weakly bound cofac-
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tors. Under the given reaction conditions, FAD proved to be
the most favored electron acceptor for StyA2B, with a catalytic
efficiency of 0.2 s1 M1. This value is about twenty times
lower than the corresponding value reported for StyB from
Pseudomonas sp. strain VLB120 (44), a fact which can be
attributed to the considerably lower turnover rate of StyA2B.
Relevance of bound flavin, heme, and metals for the oxi-
doreductase. As mentioned above, flavin is used as an exchangeable
substrate and not as a prosthetic group, which raises further ques-
tions about StyAB oxidoreductase activity. No dependence was ob-
served between the FAD oxidoreductase activity of StyA2B and the
presence of styrene, which indicates that in the absence of an aro-
FIG. 4. Multiple-sequence alignment of one- and two-component SMOs. One-component SMOs were aligned with oxygenases and reductases
of two-component SMOs, using the programs ClustalX and GeneDoc. N-terminal (3) and C-terminal (*) sequences of all proteins are indicated.
Relevant amino acid motifs for an involvement of flavin and nicotinamide adenine dinucleotides are indicated. FAD binding fingerprints GxGxxG,
GG, and Dx6G (15) were found at amino acid positions 8, 118 (StyA1, 117), and 139 (StyA1, 138), respectively. Ser46 and Pro299 (StyA1 and
Pro298) represent highly conserved amino acids necessary for SMO activity (15). The latter proline belongs to a Gdx6P sequence motif important
for FAD/NAD(P) interaction. The C-terminal reductase fragment (aa 414 to 573) of StyA2B is similar to flavin reductases which utilize NAD(P)H
as a coenzyme to reduce FMN/FAD (not shown). Shading indicates different degrees of conserved amino acid similarity (black, 100%; dark gray,
80%; gray, 60%).
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matic substrate, StyA2B acts as an NADH oxidase. In fact, hydrogen
peroxide could be detected from such conversions (data not shown).
This uncoupling reaction is typical for two-component SMOs (25,
44). On the other hand, the complete absence of NADH oxidase
activity in StyA2B without the presence of FAD clearly indicates the
necessity of an external flavin electron acceptor.
In addition to the need for an external electron acceptor,
StyA2B was analyzed for the presence of tightly bound flavin.
For that purpose, the absorbance at 450 nm of homogeneous
His10-StyA2B was compared to that of an equimolar concen-
tration of free FAD (Fig. 6b). An absorption ratio between
1:14 and 1:20 did not indicate the presence of bound flavin, at
least in a stoichiometric amount. This property distinguishes
StyA2B from flavin reductase PheA2 (28, 58), which harbors a
tightly bound FAD.
The absence of heme groups was confirmed by the insensi-
tivity of StyA2B toward metyrapone, an effective inhibitor of
cytochrome P450 enzymes (53). This result correlates with the
optical properties reported above and with the StyA2B protein
sequence in which no heme binding motif could be found.
His10-StyA2B was subjected to inhibition studies in order to
reveal information about catalytically relevant groups or spe-
cies. Chelating agents such as EDTA and o-phenanthroline
had no noticeable effect on FAD-reducing activity, indicating
that divalent anions are not necessary for catalysis. Accord-
ingly, neither 20 M of Ca2 or Mg2 nor 100 M Fe2
FIG. 5. Dendrograms showing the relationship of StyA2B to other (putative) single- and two-component (styrene) monooxygenases. Distance
trees were created with respect to the oxygenase- and flavin oxidoreductase-like moieties of StyA2B with the software programs ClustalX (version
1.8) (19, 55) and GeneDoc (version 2.6.003) and the PHYLIP 3.66 package (PROTDIST and FITCH) (16). The oxygenase and reductase
components of 4-hydroxyphenylacetate 3-monooxygenase served as the outgroup. Enzymes from R. opacus 1CP are shaded gray, those with
reported activity are underlined, and putative self-sufficient one-component SMOs are marked with asterisks. M. xanthus, Myxococcus xanthus; D.
acidovorans, Delftia acidovorans; R. solanacearum, Ralstonia solanacearum; R. palustris, Rhodopseudomonas palustris; P. fluorescens, Pseudomonas
fluorescens; P. putida, Pseudomonas putida; M. smegmatis, Mycobacterium smegmatis; L. interrogans, Leptospira interrogans; A. vinelandii, Azotobacter
vinelandii; S. coelicolor, Streptomyces coelicolor; S. arenicola, Salinispora arenicola; F. alni, Frankia alni; A. baumannii, Acinetobacter baumannii; T.
thermophilus, Thermus thermophilus.
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affected activity significantly. The insignificance of metals was
confirmed by atom emission spectroscopy, during which no
noticeable amount of Fe, Cu, Mn, Zn, Ni, or any other di- or
trivalent metal was determined.
Not surprisingly, incubation of StyA2B with 10 M Hg2 or
Cd2 resulted in considerable decreases, 64% and 44%, re-
spectively, in oxidoreductase activity. This effect is likely to be
attributed to oxidation-sensitive cysteine residues, since signif-
icant inactivation (26%) was also observed for hydrogen per-
oxide. Accordingly, reducing agents like mercaptoethanol and
DTT did not lower oxidoreductase activity, and a surplus of the
latter compound was shown to fully abolish the inhibiting effect
of Cd2 ions. Interference relevant for further kinetic studies
was shown for substrates and products of the oxygenase moiety
of StyA2B. In the presence of 2 mM styrene or thioanisole
(later shown to be favored oxygenase substrates for StyA2B),
as well as 200 M styrene oxide or methylphenylsulfoxide, only
50 to 80% of the FAD oxidoreductase turnover rate was ob-
served.
Similar results in respect to the relevance of metals, the
impact of certain inhibitors, and the absence of tightly bound
flavin were reported for the two-component SMO from
Pseudomonas sp. strain VLB120 (44). Thus, StyA2B indeed
seems to represent a simple fusion between the moieties of a
classical two-component SMO without a noticeable change in
catalytically relevant groups.
Parameters affecting His10-StyA2B activity. Initial attempts
to remove the histidine tag from the recombinant His10-
StyA2B by proteolytic treatment with factor Xa (3.3 U nmol1
His-StyA2B; 21°C; 18 h) resulted in a drastic decrease of about
80% in FAD oxidoreductase activity. As a consequence, bio-
chemical characterizations were performed with the His-
tagged protein, keeping in mind that the N-terminal modifica-
tion might influence catalytic behavior.
The optimum temperature for FAD oxidoreductase activity
of recombinant StyA2B is about 37°C (Fig. 7b). The pH de-
pendence of FAD oxidoreductase activity was determined, and
the maximum pH was found to be 6.25 in Bis-Tris HCl (Fig.
7a). For a certain pH, it was observed that activity was greatly
dependent on the applied buffer system.
Overall, the chosen standard assay conditions (30°C; Tris
HCl; pH 7.5) were suboptimal and led to a limitation of activ-
ities to about 25% of the theoretical performance; however,
these parameters reflect efforts to minimize acid-catalyzed
epoxide hydrolysis and substrate evaporation.
StyA2B acts as an oxygenase with specificity for styrene and
structurally related compounds. The monooxygenase activity
and specificity of StyA2B were investigated with a coupled-
enzyme assay in which the flavin oxidoreductase activity of
StyA2B was used to generate reduced FAD. In addition, for-
mate dehydrogenase-formate and catalase were included for
the regeneration of NADH and for the removal of hydrogen
peroxide, respectively. Care was taken that neither the NADH
regeneration system nor the substrate and oxygen concentra-
tion was limiting to the monooxygenase activity.
Styrene, 4-chlorostyrene, and 4-methylstyrene all proved to
be suitable substrates for recombinant His10-StyA2B and were
converted to the corresponding styrene oxides with specific
activities of 6 to 19 mU mg1 (Table 4). Epoxidation of the
parent compound by whole-cell biotransformation with E. coli
BL21(pSRoA2B_P01) was shown to be highly enantioselec-
tive, yielding (S)-styrene oxide in 94% enantiomeric excess
(e.e.). Perceptibly lower enantioselectivity was shown for
FIG. 6. SDS-PAGE (a) and UV-visible absorption spectrum (b) of
His10-StyA2B. (a) A 10% polyacrylamide gel was loaded as follows:
lane M, PageRuler 10- to 200-kDa protein ladder (Fermentas); lane 1,
crude extract of noninduced E. coli BL21(pSRoA2B_P01); lane 2,
crude extract of induced E. coli BL21(pSRoA2B_P01); lane 3, 1.6 g
His10-StyA2B from Ni chelate chromatography. (b) UV-visible absorp-
tion spectra of 22.4 M purified His10-StyA2B and a similar concen-
tration of FAD in 10 mM Tris HCl (pH 7.5).
TABLE 3. Kinetic parameters for FAD oxidoreductase activity of StyA2B toward different flavins (electron acceptors) and electron donorsa
Electron donor
(concn M)
Electron acceptor
(concn M) Km (M) Vmax (U mg
1) kcat (s1)
kcat Km
1
(s1 M1)
% Relative
kcat Km
1
NADH (17.5–175) FAD (50) 58  9 3.7 3.9  0.3 0.068 100
NADPH (175) FAD (50) ND 0.01 ND ND ND
NADH (175) FAD (4–60) 26  2 4.9 5.2  0.2 0.203 100
NADH (175) Riboflavin (4–60) 23  2 2.8 3.0  0.1 0.131 64
NADH (175) FMN (4–60) 67  22 4.5 4.8  1.0 0.071 35
a Activities were determined by the standard flavin oxidoreductase assay, applying 16.1 g of His10-StyA2B from R. opacus 1CP. Km and Vmax were calculated by the
initial rate method and nonlinear regression analysis (DynaFit, version 3.28.059; curves are presented in Fig. S3 in the supplemental material) (30). ND, not determined.
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4-chlorostyrene, which yielded the (S)-epoxide in 82% e.e.
Two-component SMOs from pseudomonads were reported to
possess enantioselectivities of 98% e.e. toward these sub-
strates (21, 60); however, the relative activities of styrene(s) are
comparable to those for StyA2B. This is also true for the
conversion of dihydronaphthalene (one of the best substrates
of StyA/StyB [21]) and thioanisole (Table 4). Sulfoxidation of
the latter to phenylmethylsulfoxide seems to be a common
property among SMOs. No activity was measured for ethyl-
benzene, and the inability of StyA2B to convert acetophenone
excluded a hydroxylase or a Baeyer-Villiger oxygenase.
In contrast to the similarities in substrate specificity, the
specific monooxygenase activities of recombinant StyA2B from
R. opacus 1CP were found in general to be at least one order
of magnitude lower than those ones reported for StyA/StyB
(21, 44) and SMO/PheA (60) (Table 4).
Conclusions. The evolution of enzymes develops from single
active units toward complex multifunctional systems (48).
Gene fusion is probably the simplest of the processes that
enhance the overall complexity of a discrete protein by com-
bining different functionalities of its ancestors. Compensation
for the so-called phenomenon of intracellular crowding (10),
benefiting kinetically by the close proximity of active sites (38),
and coordinated regulation of expression that prevents meta-
bolic cross talk between competing pathways are the major
driving forces of multifunctional enzyme systems.
The self-sufficient SMO StyA2B from R. opacus 1CP de-
scribed herein is likely to be an example of such an evolution-
ary process in which both genes of two-component SMOs en-
coding an oxygenase (StyA2) and a flavin oxidoreductase
subunit (StyB) have been merged. StyA2B is able to oxidize
styrene and structurally related compounds to the correspond-
ing oxides at the expense of NADH. An externally provided
flavin-containing cofactor that must first be reduced by the
reductase domain is necessary as an electron mediator in order
to activate dioxygen. The specificities of StyA2B toward the
oxygenation substrates styrene, dihydronaphthalene, and phe-
nylmethylsulfide strongly resemble those of oxygenases of re-
ported two-component SMOs (44, 60). The same is true for the
oxidoreductase specificity of StyA2B for electron donors
[NAD(P)H] and electron acceptors (FAD, FMN, and ribofla-
vin) compared to those of reductases of two-component SMOs
(44). In addition, the absence of heme groups and metal ions
and the weak binding of flavin in the recombinant His-tagged
fusion protein correlate with the StyA/StyB system of Pseudo-
monas sp. strain VLB120 (44) and indicate that catalytically
relevant groups are basically similar. The relatively low affinity
of the oxidoreductase domain of StyA2B toward several flavin-
containing cofactors indicates a weak binding of these cofac-
tors, which is consistent with the absence of flavin binding
sequence motifs and is probably a result of the isoalloxazine
ring, not the nucleotide groups, as with most other flavopro-
teins, being favored for recognition. Another alternative bind-
ing mechanism of the oxidoreductase is likely to exist for
NADH. This cofactor might bind in a solvent-accessible
groove, adopting an unusual folded conformation with ring
stacking, as was recently shown for a flavin reductase PheA2 of
Geobacillus thermoglucosidasius A7 (58).
The low specific activity of StyA2B was an unexpected find-
ing for this first type of fusion between a flavin-dependent
monooxygenase and a flavin reductase. FAD-reducing and sty-
rene-oxidizing activities of StyA2B were determined to be one
to two orders lower than the corresponding values for the
StyA/StyB system of strain VLB120. This is especially unex-
pected considering the situation in P450 monooxygenases, for
which such fusions are more often found. The first and by far
best-characterized representative of these cytochrome P450
fusions is the P450BM3 fatty acid hydroxylase of Bacillus mega-
terium, in which the P450 domain is merged to an eukaryotic-
like cytochrome P450 reductase (40). Like most other recently
identified P450-redox partner fusion enzymes, these systems
are characterized by enhanced catalytic efficiency (7, 8, 39).
Whereas the Km values of P450BM3 for several fatty acid
substrates are comparable to those of eukaryotic fatty acid
hydroxylases, the turnover rates for hydroxylation (up to 270
s1) are at least two orders higher than those observed for the
latter group of enzymes. In the fused BM3 system, the prox-
imity of the FMN and heme domain ensures an increase in the
productivity of the interaction, thus reducing the rate of un-
productive decomposition of the unstable ferrous-oxygen–
P450 complex and the formation of oxidative stress (38, 39).
The lack of structural data for StyA2B does not allow a
FIG. 7. pH (a) and temperature (b) dependence of the FAD oxi-
doreductase activity of StyA2B. The standard assay for flavin oxi-
doreductase activity was performed, applying the recombinant His10-
tagged protein in 20 mM of the appropriate buffer at 30°C (a) or in 20
mM Tris HCl (pH 7.5) (b) at various temperatures. Each datum point
indicates the relative activity derived from triplicate measurements.
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prediction of the distance between the styrene binding pocket
and the flavin-reducing site. Nevertheless, because of the in-
stability of reduced flavin and the rate-limiting diffusion of this
cofactor between the active sites of reductase and oxygenase,
fusion proteins should be kinetically favored in a similar way,
as was observed for P450BM3. There may be several reasons for
the observed contrary effect, of which the most likely ones
could be partial misfolding of the recombinant protein, weak
flavin binding, or structural interference of the N-terminal His
tag. With respect to the unexpectedly low oxygenating activity,
a hitherto overlooked role of the neighboring gene styA1
comes into focus. The encoded protein, a putative styrene
oxygenase component of a two-component SMO system, needs
a specific FAD oxidoreductase counterpart for activity. Genes
of two-component SMOs are typically closely located (1, 5),
which is not true of R. opacus 1CP and A. aurescens TC1.
Moreover, no styB-like gene could be identified on the basis of
sequence similarity in strain TC1. Since StyA2B represents a
merged StyB variant, a productive interaction with StyA1 is
likely and may yield additional oxygenating activity. In addition
to structural investigations of the StyA2B enzyme, a closer look
at the synergetic effects between these proteins will be neces-
sary in order to understand the evolutionary benefit of this
novel fusion protein.
StyA2B is the first active representative of a self-sufficient
SMO; however, similar fusion proteins were found in A. au-
rescens TC1 and N. farcinica IFM10152 (60). Like R. opacus
1CP, both species belong to the high-GC gram-positive phylum
Actinobacteria. Comparison of the localization of styA2B with
the corresponding genomic regions of the above organisms
gave further evidence that a similar physiological function in
styrene metabolism via PAA can be expected. The observation
that virtually no fusion proteins of noticeable similarity are
encoded within the sequenced genomes of gram-negative bac-
teria might indicate that self-sufficient SMOs may have evolved
in and are a special feature of gram-positive prokaryotes. This
assumption is not an unlikely hypothesis, since evidence of
independent evolution of metabolic pathways between pro-
teobacteria and Actinobacteria are frequently found, e.g., in the
pathways of chlorocatechols (12, 37), catechol (11, 13), and
protocatechuate (14).
SMOs represent only a small proportion of flavoprotein
monooxygenases (57, 60), and among SMOs that are distrib-
uted with a genome frequency of 0.068 (21 SMOs from 309
TABLE 4. Substrate specificity and stereoselectivity of StyA2B oxygenase activity and comparison to data of oxygenases from
two-component SMOs
Substrate Product
StyA2B (R. opacus 1CP)a,e StyA and StyB(Pseudomonas sp. strain VLB120)b,e
SMO (unknown metagenome) and
PheA2 (G. thermoglucosidasius)c,e
Oxygenase
activity
(U mg1)
Favored
enantiomer e.e. (%)
Oxygenase
activity
(U mg1)
Favored
enantiomer e.e. (%)
Oxygenase
activity
(U mg1)
Favored
enantiomer e.e. (%)
0.019 (S) 94
0.268 (S)
0.80 (S) 990.204 (S) 98.0
2.1d (S)
0.011 ND 82 0.312 ND 98.1 0.23 (S) 99
0.006 ND 0.312 ND ND ND ND ND
0.011 ND 0.376 ND 98.9 ND ND ND
0.012 ND 0.226 ND 26 0.11 (R) 75
a Oxygenase and FAD oxidoreductase components (hosts). Data were obtained from this study.
b StyA (Pseudomonas sp. strain VLB120) is the oxygenase component (host); StyB (Pseudomonas sp. strain VLB120) is the FAD oxidoreductase component (host).
StyB activity was replaced by electrochemical FAD regeneration. From references 21 and 44.
c SMO (unknown metagenome) is the oxygenase component (host); PheAZ (G. thermoglucosidasius) is the FAD oxidoreductase component (host). From
reference 60.
d Data were obtained from recombinant enzymes and an optimized StyA/StyB ratio (44).
e ND, not determined.
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genomes [57]), one-component SMOs form a novel class of
flavin-dependent monooxygenases. Regardless of the low spe-
cific activity of the herein reported recombinant His10-StyA2B,
this subclass of SMOs should be further characterized. The
activities of wild-type and mutant enzymes, the efficiency of
flavin transfer, the interaction of StyA2B and StyA1, and bio-
technological applicability are especially valuable targets of
future study.
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